Myocarditis: causes, mechanisms, and evolving therapies.
Tin KyawGrant DrummondAlex BobikKarlheinz PeterPublished in: Expert opinion on therapeutic targets (2023)
Vaccination is an excellent emerging preventative strategy for viral myocarditis, but most vaccines still require further development. Anti-viral treatments that inhibit viral replication need to be considered following viral infection in host myocardium, as lower viral load reduces inflammation severity. Understanding how the immune system continues to damage the heart even after viral clearance will define novel therapeutic targets/strategies. We propose that viral myocarditis can be best treated using a combination of antiviral agents and immunotherapies that control cytotoxic T cell activity.